EZZ Life Science Holdings (ASX:EZZ) Price-to-Owner-Earnings : (As of Jun. 08, 2024)

View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Price-to-Owner-Earnings?

As of today (2024-06-08), EZZ Life Science Holdings's share price is A$1.095. EZZ Life Science Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for EZZ Life Science Holdings's Price-to-Owner-Earnings or its related term are showing as below:

ASX:EZZ's Price-to-Owner-Earnings is not ranked ^*
in the Biotechnology industry.
Industry Median: 33.7
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-08), EZZ Life Science Holdings's share price is A$1.095. EZZ Life Science Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.08. Therefore, EZZ Life Science Holdings's PE Ratio for today is 13.35.

As of today (2024-06-08), EZZ Life Science Holdings's share price is A$1.095. EZZ Life Science Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was A$0.08. Therefore, EZZ Life Science Holdings's PE Ratio without NRI for today is 13.35.

During the past 4 years, EZZ Life Science Holdings's highest PE Ratio without NRI was 18.71. The lowest was 5.00. And the median was 8.00.

EZZ Life Science Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for EZZ Life Science Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Price-to-Owner-Earnings Chart

EZZ Life Science Holdings Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Price-to-Owner-Earnings

EZZ Life Science Holdings Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Owner-Earnings	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of EZZ Life Science Holdings's Price-to-Owner-Earnings

For the Biotechnology subindustry, EZZ Life Science Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EZZ Life Science Holdings's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EZZ Life Science Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where EZZ Life Science Holdings's Price-to-Owner-Earnings falls into.

EZZ Life Science Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

EZZ Life Science Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	1.095	/	0.00
	=

EZZ Life Science Holdings (ASX:EZZ) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

EZZ Life Science Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

EZZ Life Science Holdings (ASX:EZZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Price-to-Owner-Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

104 Derby Street, Silverwater, NSW, AUS, 2128

Website

https://www.ezzlife.com.au

EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines